Brief: Index Pharmaceuticals Evaluates Strategic Alternatives
21/02/2024 07:15
Feb 21 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* WE HAVE BEEN EVALUATING POSSIBLE PATHS FORWARD FOR INDEX
* VARIOUS ALTERNATIVES ARE BEING CONSIDERED, FOR EXAMPLE
LIQUIDATION, REVERSE MERGER, AND PUBLIC BIDS
Source text for Eikon: ID:nWkrc9CGzM
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))